Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I).
about
Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretomeMyopathy in Gaucher disease.Molecular Genetics and Metabolism Report Long-term follow-up of post hematopoietic stem cell transplantation for Hurler syndrome: clinical, biochemical, and pathological improvements.Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I.Ultrasonographic Features of Hip Joints in Mucopolysaccharidoses Type I and II.Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure.Current and emerging therapies for the lysosomal storage disorders.Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases.Enzyme replacement therapy for Mucopolysaccharidosis Type I among patients followed within the MPS Brazil Network.Bone marrow adipose tissue: formation, function and regulation.Sphingolipids: the nexus between Gaucher disease and insulin resistance.Mucopolysaccharidoses.Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.Lysosomal storage disorders: A review of the musculoskeletal features.Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I.Restricted joint range of motion in patients with MPS II: correlation with height, age and functional status.Characterization of joint disease in mucopolysaccharidosis type I mice.
P2860
Q30496213-804CA135-4760-4BC0-8F23-D58E7818D533Q33378286-0AE61364-142B-4F1E-93C1-2BDBB2D085D1Q35104361-FC90D80D-CECA-4609-88D5-EE42B199BC78Q35153234-6396CD2F-19BE-4A4F-BD01-728710EC1761Q35553148-1B306BF2-B88D-41E5-ABD3-C2842FE02071Q36048779-69CCE5C2-7CEE-4EBE-B709-08985E17784CQ36302871-4C07DA1E-CAC0-4A59-8FAF-2269BD00ED2BQ36357390-B2A21EA1-C4D9-475D-91BF-408C597F6015Q37644409-56A1F7C8-DBDF-4548-8E88-7652AD2904E7Q37701441-620D93DD-B079-4CB4-B109-B1AF3C0DA007Q37799400-D4D88AF9-FB2C-4AA3-B1C1-9ED813A2BFB0Q38165092-CDF11F19-3123-4174-BC5F-3D250DFD2B9DQ38262722-70F25F38-B258-4408-8843-FE2A7BFF9C26Q38819947-3FEC74E6-43D4-4FDF-B4DA-321D83593604Q45879685-81E8638B-F51B-41C3-89BB-11A1ECE6B14DQ47344483-DE8E903A-89F2-42BB-A20D-94C425492A93Q50489476-87F5E1AE-BE2B-43CA-9778-00D3159637E6
P2860
Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Musculoskeletal complications ...... mucopolysaccharidosis type I).
@ast
Musculoskeletal complications ...... mucopolysaccharidosis type I).
@en
type
label
Musculoskeletal complications ...... mucopolysaccharidosis type I).
@ast
Musculoskeletal complications ...... mucopolysaccharidosis type I).
@en
prefLabel
Musculoskeletal complications ...... mucopolysaccharidosis type I).
@ast
Musculoskeletal complications ...... mucopolysaccharidosis type I).
@en
P1476
Musculoskeletal complications ...... mucopolysaccharidosis type I).
@en
P2093
Gregory M Pastores
Patrick A Meere
P356
10.1097/01.BOR.0000147283.40529.13
P577
2005-01-01T00:00:00Z